Search Results

The default setting for search results displays All Content. If you prefer to see recent content only, please adjust the date filter.

16 Results Found

Letter/Comment
Public

AHA Response to OMB Deregulation RFI

AHA responds to the Office of Management and Budget Deregulation Request for Information.
Letter/Comment
Public

AHA Comments on 340B Drug Pricing Program, IRF Payments, Physician Fee Schedule and Telehealth

AHA comments on MedPAC topics to be considered in the new cycle: the 340B Drug Pricing Program, inpatient rehabilitation facility (IRF) payments, the physician fee schedule (PFS) and telehealth.
Letter/Comment
Public

AHA Letter of Support for the Telehealth Modernization Act (H.R. 7623)

The AHA voices support of the Telehealth Modernization Act (H.R. 7623).
Letter/Comment
Public

CMS Urged to Remove Telehealth Provider Home Address Reporting Requirements

AHA urges the Centers for Medicare & Medicaid Services to remove the requirement that telehealth providers list their home address on enrollment and claims forms when performing services from their homes.
Letter/Comment
Public

AHA Urges Congress to Act on Key Priorities in Lame-duck Session

AHA letter urging Congress to act on key priorities in Lame-duck session.
Letter/Comment
Public

AHA Comments on CMS Physician Fee Schedule CY 2025 Proposed Rule

The AHA urges CMS to work with Congress to provide a Physician Fee Schedule payment increase for 2025 and to develop a long-term plan for sustainable physician payment.
Letter/Comment
Public

AHA Urges Congress to Address Addiction Treatment Barriers

AHA respond to Reps. Paul Tonko and Mike Turner's questions about how hospitals and health systems across the country are working to expand access to addiction treatment and what additional steps Congress can take to eliminate the remaining barriers.
Letter/Comment
Public

AHA Requests Flexibility Extension from HHS on DEA Telemedicine Prescribing

AHA letter to HHS regarding the Department of Health and Human Services 'role in coordinating with the Drug Enforcement Administration to support the safe prescribing of controlled substances via telehealth.
Letter/Comment
Public

AHA Requests Flexibility Extension on DEA Telemedicine Prescribing

AHA comments to the Drug Enforcement Administration regarding their efforts to support the safe prescribing of controlled substances via telehealth. Indeed, during the COVID-19 public health emergency
Letter/Comment
Public

AHA Letter to Senate Finance Committee on Medicare Part B White Paper

AHA's comment on the Senate Finance Committee white paper on Bolstering Chronic Care through Physician Payment, Current Challenges and Policy Options in Medicare Part B.